Galmed Pharmaceuticals Reports First Quarter 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Galmed Pharmaceuticals Reports First Quarter 2017 Financial Results

Galmed Pharma (GLMD) Tops Q1 EPS by 12c

May 15, 2017 8:02 AM EDT

Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of ($0.26), $0.12 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $260 thousand.

Net loss of $3.2 million, or $0.26 per share, for the three months ended March 31, 2017, compared to a net loss of $4.0 million, or $0.36 per share, for the three months ended March 31, 2016. This period\'s net loss... More